Lista de obras -

Advanced nanomedicines for the treatment of inflammatory diseases

artículo científico publicado en 2020

Assessment of chimerism in epithelial cancers in transplanted patients

artículo científico publicado en 2014

Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.

artículo científico publicado en 2011

Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma

artículo científico publicado en 2016

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma ⬇️

artículo científico publicado el 9 de septiembre de 2010

Detection of plasmonic nanoparticles with full field-OCT: optical and photothermal detection

artículo científico publicado en 2014

Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis.

artículo científico publicado en 2013

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

artículo científico

Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant

artículo científico publicado en 2012

Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation

artículo científico publicado en 2008

Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells

artículo científico publicado en 2009

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

artículo científico publicado en 2007

Gold nanoparticles in cardiovascular imaging

artículo científico publicado en 2017

Human skin carcinoma arising from kidney transplant-derived tumor cells

artículo científico publicado en 2013

Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy

artículo científico publicado en 2013

Nanomedicine as a strategy to fight thrombotic diseases.

artículo científico publicado en 2015

Nanomedicine for the molecular diagnosis of cardiovascular pathologies

artículo científico

Nanoplumbers: biomaterials to fight cardiovascular diseases

Necrosis assessment in renal carcinoma

artículo científico publicado en 2012

Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation

artículo científico publicado en 2020

Squalene-based nanoparticles for the targeting of atherosclerotic lesions

scientific article published on 04 April 2020

Stability of preclinical models of aggressive renal cell carcinomas

artículo científico publicado en 2014

Stem cells increase in numbers in perinecrotic areas in human renal cancer.

artículo científico publicado en 2014

TP53 status and response to chemotherapy in breast cancer

artículo científico publicado en 2008

TP53 status and response to treatment in breast cancers

artículo científico publicado en 2011

The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe

artículo científico publicado en 2009

Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma

artículo científico publicado en 2015

Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles

scientific article published on 29 June 2019

Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.

artículo científico publicado en 2017

Validation of a preclinical model for assessment of drug efficacy in melanoma

artículo científico publicado en 2016

[Mechanisms of resistance to inhibitors of the VEGF pathway]

artículo científico publicado en 2010

p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors.

artículo científico publicado en 2009

p53 in breast cancer subtypes and new insights into response to chemotherapy

artículo científico

Lista de obras de

Advanced nanomedicines for the treatment of inflammatory diseases

Assessment of chimerism in epithelial cancers in transplanted patients

Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.

Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma ⬇️

Detection of plasmonic nanoparticles with full field-OCT: optical and photothermal detection

Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis.

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant

Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation

Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

Gold nanoparticles in cardiovascular imaging

Human skin carcinoma arising from kidney transplant-derived tumor cells

Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy

Nanomedicine as a strategy to fight thrombotic diseases.

Nanomedicine for the molecular diagnosis of cardiovascular pathologies

Nanoplumbers: biomaterials to fight cardiovascular diseases

Necrosis assessment in renal carcinoma

Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation

Squalene-based nanoparticles for the targeting of atherosclerotic lesions

Stability of preclinical models of aggressive renal cell carcinomas

Stem cells increase in numbers in perinecrotic areas in human renal cancer.

TP53 status and response to chemotherapy in breast cancer

TP53 status and response to treatment in breast cancers

The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe

Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma

Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles

Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.

Validation of a preclinical model for assessment of drug efficacy in melanoma

[Mechanisms of resistance to inhibitors of the VEGF pathway]

p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors.

p53 in breast cancer subtypes and new insights into response to chemotherapy